| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/27/2004 | WO2004043948A1 Sulfonamides |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2004043939A1 Amide compounds and methods of using the same |
| 05/27/2004 | WO2004043918A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/27/2004 | WO2004043917A1 Sulfonamides |
| 05/27/2004 | WO2004043916A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/27/2004 | WO2004043912A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/27/2004 | WO2004043907A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/27/2004 | WO2004043884A2 Novel acylating reagents |
| 05/27/2004 | WO2004043463A2 Sulfonamides |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004043369A2 Sulfonamides |
| 05/27/2004 | WO2004043366A2 Sulfonamides |
| 05/27/2004 | US20040102646 Method of resolving optical isomers of amino acid derivative |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102511 HMG-CoA reductase inhibitors; anticholesterol; statins; potency greater than atorvastatin; amidation of the b-keto ester with an amine, reaction with an aldehyde; cyclization |
| 05/27/2004 | US20040102490 Antilipemic agents, antidiabetic agents and treatment of obesity |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102482 Antibacterial Mutilins |
| 05/27/2004 | US20040102431 Protease inhibitors |
| 05/27/2004 | US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure |
| 05/27/2004 | US20040102338 Liquid intermediates; easy handling; lube oil detergents and dispersants; pour point depressants; paper surface sizing agents |
| 05/27/2004 | US20040101864 Chemical process |
| 05/27/2004 | US20040101446 Arrays and artificial receptors |
| 05/27/2004 | US20040100188 Anthracene derivative and organic electroluminescence device using the derivative |
| 05/27/2004 | DE10252275A1 Perfluoralkylaniline Perfluoralkylaniline |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | CA2505365A1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/27/2004 | CA2505098A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/27/2004 | CA2503992A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/26/2004 | EP1422553A1 Improved base precursors for use in a photothermographic element |
| 05/26/2004 | EP1422218A1 Antiviral agent |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421827A1 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 05/26/2004 | EP1421063A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 05/26/2004 | EP1421057A1 Chemotherapeutic agents |
| 05/26/2004 | EP1421056A1 (alpha)-haloenamine reagents |
| 05/26/2004 | EP1420782A1 Use of nefiracetam for treating neurodegeneration |
| 05/26/2004 | EP1420781A2 Analgetic pyrroline derivatives |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1206446B1 Carboxylic acid amides, their production and their use as drugs |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | CN1499967A Kappa opiate agonists for treatment of bladder diseases |
| 05/26/2004 | CN1151130C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 05/26/2004 | CN1151126C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740675 3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| 05/25/2004 | US6740674 Administering formulation comprising proteasome inhibitor in carrier for therapy of dry eye disorder |
| 05/25/2004 | US6740153 Air oxidizing a pyrrolinone in the presence of an anthraquinone catalyst |
| 05/25/2004 | CA2267059C Sordarin derivatives |
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041795A1 Novel inhibitors of dipeptidyl peptidase iv |
| 05/21/2004 | WO2004041217A2 Synthetic lactone formulations and method of use |
| 05/21/2004 | WO2004041211A2 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT |
| 05/21/2004 | WO2003086605A3 Functionalized ionic liquids, and methods of use thereof |
| 05/21/2004 | WO2002088082A3 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |
| 05/21/2004 | CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097740 Reacting azides with a trialkylphosphine, a triarylphoshine, a trialkyl phosphite or a reducing agent in the presence of a diluent and, if appropriate, a catalyst |
| 05/20/2004 | US20040097732 Peptide deformylase inhibitors |
| 05/20/2004 | US20040097578 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 05/20/2004 | US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
| 05/20/2004 | US20040096976 Block immobilized om a support; coupling; biosynthesis |
| 05/20/2004 | US20040096908 Methods of using arrays and artificial receptors |
| 05/19/2004 | EP1419160A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |
| 05/19/2004 | EP1419144A2 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues |
| 05/19/2004 | EP1418905A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/19/2004 | EP1202956B1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498208A Carboxamides as fungicides in agriculture |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders |
| 05/19/2004 | CN1150162C Biphenylamidine derivatives |
| 05/19/2004 | CN1149990C Cyclooxygenase-2 inhibitor for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 05/18/2004 | US6737437 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737429 Pyrrole derivatives |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737409 For cancer therapy |
| 05/13/2004 | WO2004039843A1 Immunoglobulin g binding pocket |
| 05/13/2004 | WO2004039795A2 Amide compounds for the treatment of hyperlipidemia |
| 05/13/2004 | WO2004039788A1 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 05/13/2004 | WO2004039785A1 Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination |
| 05/13/2004 | WO2004039768A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof |
| 05/13/2004 | WO2004039765A1 Use of urea variants as affinity ligands |
| 05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 05/13/2004 | WO2004039367A1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004005392A3 Maleimidopropyl trimethoxysilane and related free-radically polymerizable coupling agents as adhesion promotors in adhesive formulations |
| 05/13/2004 | WO2003101449A3 Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof |
| 05/13/2004 | WO2003045977A3 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 05/13/2004 | WO2002072073A3 Pharmaceutical formulation comprising atorvastatin calcium |
| 05/13/2004 | WO2002059240A3 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions |